TORONTO, ON / ACCESSWIRE / August 20, 2020 / Newtopia Inc. (TSXV:NEWU), a tech-enabled disease prevention company focused on healthy habit change, today announced it will be presenting at the LD 500 virtual investor conference which is being held September 1-4, 2020.
Newtopia’s management is scheduled to present on Thursday September 3, 2020 at 3:20 PM ET with one-on-one meetings held throughout the conference.
To register and book a meeting: https://ld-micro-conference.events.issuerdirect.com/
Webcast: https://www.webcaster4.com/Webcast/Page/2019/36822
View Newtopia’s profile here: https://www.ldmicro.com/profile/NEWU.V
About Newtopia
Newtopia is a tech-enabled disease prevention company focused on healthy habit change. Newtopia’s platform leverages genetic, social and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans. To learn more, visit newtopia.com.
Profiles powered by LD Micro – News Compliments of ACCESSWIRE
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. The upcoming “500” in September is the Company’s most ambitious project yet, and the first event that is accessible to everyone.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
For further information, please contact:
Media Contact:
Rikki Bennie, rbennie@newtopia.com, 1.888.639.8181 ext 208
SOURCE: Newtopia Inc. via LD Micro
View source version on accesswire.com:
https://www.accesswire.com/602652/Newtopia-to-present-at-the-LD-500-Virtual-Conference-on-September-3-2020
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the…
Shrivers Hospice sets a benchmark for quality care in Ohio with prestigious award LOS ANGELES,…